Clinical Handbook of Psychotropic Drugs, 25th Edition (PDF)

30 $

Delivery time: Maximum to 1 hours

Format : Publisher PDF

File Size : 7 MB

The Clinical Handbook of Psychotropic Drugs is a comprehensive guide for psychiatric professionals including doctors, nurses, and pharmacists. It contains up-to-date information, comparison charts, and tables for quick decision making, along with icons and full color for easy reference. The book covers on- and off-label indications, side effects, interactions, pharmacodynamics, precautions, nursing implications, and patient information sheets. The 25th edition includes updates on antidepressants, antipsychotics, mood stabilizers, dementia, substance use disorders, unapproved treatments, natural health products, and pharmacogenetics. It is a spiral-bound book consisting of 480 pages and is published by HOGRE.

Category: Medical Book

Description

Clinical Handbook of Psychotropic Drugs, 25th Edition (PDF Book)

The Clinical Handbook of Psychotropic Drugs: A Must-Have Reference for Mental Health Professionals

By Ric M. Procyshyn, Kalyna Z. Bezchlibnyk-Butler, David D. Kim

Comprehensive and rapid information regarding psychotropic drugs in adults.

– Precise and current

– Comparison graphs facilitate decision making

Icons and colorful images

– available in print and online

– Pamphlets that can be downloaded and printed out for patients.

The Clinical Handbook of Psychotropic Medicines has become a common reference and practical tool for psychiatrists, psychologists, doctors, pharmacists, nurses, and other healthcare professionals.

• Independent, objective, and current

• Filled with unique, simple to read comparison graphs and tables (dosages, effects, pharmacokinetics, interactions…

• succinct, listed information regarding all classes of medication, including on-label and off-label uses, side effects, interactions, pharmacodynamics, and precautions in the young, elderly, and pregnant women, as well as the information you need to know about each class of drug.

• Future planned interactions and effects that are summarized in a comparison chart.

• With easily identificable icons and which are colorful and full of information, it allows you to find what you want quickly.

Patients’ information is documented in a clear and concise manner, which can be accessed easily as a printable PDF.

This book is essential for anyone who wants an up-to-date, simple to use, and comprehensive description of all of the most important information regarding psychotropic drugs.

New this year:

• The antidepressants chapter includes a new section on the combination of a NMDA receptor antagonist and a CYP2D6 inhibitor (dextromethorphan/bupropion; Auvelity extended-release tablets)

Antipsychotics updates include a revised table of monitoring Clozapine that now includes a requirement to monitor patients with or without ethnic neutropenia that is non-benign.

• Mood stabilizers sections on lithium and Anticonvulsants were greatly revised.

• The Dementia chapter contains a new section on Lecanemab (Leqembi), a rapid-track treatment that is approved by the FDA for the treatment of Alzheimer’s disease.

The procedure of treating Substance Use Disorders involves altering the way Buprenorphine is dosed, this alteration involves a rapid micro-induction method that is specific to the Bernese method, this method allows for the treatment of a patient without having to wait for them to enter withdrawal.

Approved and unapproved treatments of psychiatric disorders, natural health products, and genetic modifications to pharmaceuticals have all been significantly revised.

New formulations and trademark names include: Invega Hafyera (paliperidone that lasts for 6 months), Subutex (buprenorphine that is sublingual), Quviviq (daridorexant that is sublingual), and Invega Haffyera (paliperidone that lasts for 12 months).